These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9829633)

  • 41. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Significance of monoclonal antibodies against the conserved epitopes within non-structural protein 3 helicase of hepatitis C virus.
    Bian Y; Zhao S; Zhu S; Zeng J; Li T; Fu Y; Wang Y; Zheng X; Zhang L; Wang W; Yang B; Zhou Y; Allain JP; Li C
    PLoS One; 2013; 8(7):e70214. PubMed ID: 23894620
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibodies Targeting Novel Neutralizing Epitopes of Hepatitis C Virus Glycoprotein Preclude Genotype 2 Virus Infection.
    Deng K; Liu R; Rao H; Jiang D; Wang J; Xie X; Wei L
    PLoS One; 2015; 10(9):e0138756. PubMed ID: 26406225
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isolation and epitope characterization of human monoclonal antibodies to hepatitis C virus core antigen.
    Siemoneit K; da Silva Cardoso M; Wölpl A; Koerner K; Subanek B
    Hybridoma; 1994 Feb; 13(1):9-13. PubMed ID: 7515376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33.
    Tarr AW; Owsianka AM; Timms JM; McClure CP; Brown RJ; Hickling TP; Pietschmann T; Bartenschlager R; Patel AH; Ball JK
    Hepatology; 2006 Mar; 43(3):592-601. PubMed ID: 16496330
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
    León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM
    Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monoclonal Antibodies Directed toward the Hepatitis C Virus Glycoprotein E2 Detect Antigenic Differences Modulated by the N-Terminal Hypervariable Region 1 (HVR1), HVR2, and Intergenotypic Variable Region.
    Alhammad Y; Gu J; Boo I; Harrison D; McCaffrey K; Vietheer PT; Edwards S; Quinn C; Coulibaly F; Poumbourios P; Drummer HE
    J Virol; 2015 Dec; 89(24):12245-61. PubMed ID: 26378182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies.
    Muerhoff AS; Gutierrez R; Kyrk C; Leary T; Schlauder G; Dawson G; Desai SM
    J Med Virol; 2008 Mar; 80(3):411-8. PubMed ID: 18205228
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunogenicity of variable regions of hepatitis C virus proteins: selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA.
    Rodr Guez-L Pez M; Riezu-Boj JI; Ruiz M; Berasain C; Civeira MP; Prieto J; Borr S-Cuesta F
    J Gen Virol; 1999 Mar; 80 ( Pt 3)():727-738. PubMed ID: 10092013
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human recombinant antibodies specific for hepatitis C virus core and envelope E2 peptides from an immune phage display library.
    Chan SW; Bye JM; Jackson P; Allain JP
    J Gen Virol; 1996 Oct; 77 ( Pt 10)():2531-9. PubMed ID: 8887487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of immunodominant regions and linear B cell epitopes of the gE envelope protein of varicella-zoster virus.
    Fowler WJ; Garcia-Valcarcel M; Hill-Perkins MS; Murphy G; Harper DR; Jeffries DJ; Burns NR; Adams SE; Kingsman AJ; Layton GT
    Virology; 1995 Dec; 214(2):531-40. PubMed ID: 8553555
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Simultaneous detection of anti-HCV antibody and HCV core antigen.
    Ansaldi F; Icardi G
    Methods Mol Biol; 2009; 510():15-23. PubMed ID: 19009250
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simultaneous detection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay.
    Alzahrani AJ
    J Med Virol; 2008 Apr; 80(4):603-6. PubMed ID: 18297713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries.
    Bugli F; Mancini N; Kang CY; Di Campli C; Grieco A; Manzin A; Gabrielli A; Gasbarrini A; Fadda G; Varaldo PE; Clementi M; Burioni R
    J Virol; 2001 Oct; 75(20):9986-90. PubMed ID: 11559832
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis C virus core region: helper T cell epitopes recognized by BALB/c and C57BL/6 mice.
    Kakimi K; Kuribayashi K; Iwashiro M; Masuda T; Sakai M; Ling W; Kubo Y; Kobayashi H; Higo K; Seki M
    J Gen Virol; 1995 May; 76 ( Pt 5)():1205-14. PubMed ID: 7537326
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mapping of a conformational epitope shared between E1 and E2 on the serum-derived human hepatitis C virus envelope.
    Petit MA; Jolivet-Reynaud C; Peronnet E; Michal Y; Trépo C
    J Biol Chem; 2003 Nov; 278(45):44385-92. PubMed ID: 12882983
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reliability of hepatitis C virus core antigen assay for detection of viremia in HCV genotypes 1, 2, 3, and 4 infected blood donors: a collaborative study between Japan, Egypt, and Uzbekistan.
    Agha S; Tanaka Y; Saudy N; Kurbanov F; Abo-Zeid M; El-Malky M; Khalaf M; Ohta N; Yoshizawa H; Mizokami M
    J Med Virol; 2004 Jun; 73(2):216-22. PubMed ID: 15122795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients.
    Bouzgarrou N; Fodha I; Othman SB; Achour A; Grattard F; Trabelsi A; Pozzetto B
    J Med Virol; 2005 Dec; 77(4):502-8. PubMed ID: 16254976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antigenic structure of the complete nonstructural (NS) 2 and 5 proteins of hepatitis C virus (HCV): anti-HCV NS2 and NS5 antibody reactivities in relation to HCV serotype, presence of HCV RNA, and acute HCV infection.
    Zhang ZX; Chen M; Sönnerborg A; Sällberg M
    Clin Diagn Lab Immunol; 1994 May; 1(3):290-4. PubMed ID: 7496964
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of immunization in mice with recombinant DNA encoding the hepatitis C virus structural protein.
    Dou J; Liu K; Chen Z; Wo J; He N; Liu Y; Zhang M; Wang X; Xu C
    Chin Med J (Engl); 1999 Nov; 112(11):1036-9. PubMed ID: 11721468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.